BWM
CLSD

Brown Wealth Management’s Clearside Biomedical CLSD Stock Holding History

Brown Wealth Management’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,667
Closed -$80K – 100
2025
Q2 		$80K Hold
6,667
– – 0.02% 98
2025
Q1 		$91.8K Hold
6,667
– – 0.03% 93
2024
Q4 		$95K Hold
6,667
– – 0.03% 85
2024
Q3 		$127K Hold
6,667
– – 0.05% 86
2024
Q2 		$130K Sell
6,667
-666
-9% -$12.9K 0.05% 83
2024
Q1 		$168K Hold
7,333
– – 0.07% 87
2023
Q4 		$129K Hold
7,333
– – 0.06% 85
2023
Q3 		$95.7K Hold
7,333
– – 0.05% 80
2023
Q2 		$123K Buy
+7,333
New +$126K 0.06% 90

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brown Wealth Management's CLSD Position: Q3 2025 in Review

Brown Wealth Management sold out of Clearside Biomedical (CLSD) in Q3 2025, closing a stake of 6,667 shares — an estimated $80K sold.

Brown Wealth Management first reported a position in CLSD in Q2 2023 and held it in 9 quarters. The position peaked at $168K in Q1 2024. 26 funds tracked by Wall St. Rank hold CLSD as of Q3 2025.

  • Brown Wealth Management reported no remaining Clearside Biomedical position as of Q3 2025 after selling out during the quarter.
  • Brown Wealth Management sold 6,667 Clearside Biomedical shares in Q3 2025, an estimated $80K.
  • Brown Wealth Management first reported a position in Clearside Biomedical in Q2 2023 and held it in 9 quarters.
  • Brown Wealth Management's Clearside Biomedical position peaked at $168K in Q1 2024.
  • 26 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2025.

Based on Brown Wealth Management's 13F filing for Q3 2025, filed 4 Nov 2025.